Nishinomiya, Japan

Takeshi Kanno


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Takeshi Kanno

Introduction

Takeshi Kanno is a notable inventor based in Nishinomiya, Japan. He has made significant strides in the field of pharmaceuticals, particularly in the development of anticancer agents. His work is characterized by a commitment to improving cancer treatment options.

Latest Patents

Takeshi Kanno holds a patent for an anticancer agent that aims to provide a compound with an anticancer action comparable or superior to that of naftopidil. The compound is represented by the formula (I), which includes a specific structure, particularly 1-((2-((2-methoxyphenyl)amino)ethyl)amino)-3-(1-naphthyloxy)propan-2-ol, or a pharmaceutically acceptable salt thereof. This compound demonstrates a cell proliferation suppressive action on a wide range of cancer cells, making it useful for the prophylaxis and treatment of cancer.

Career Highlights

Takeshi Kanno is associated with Ktn Biotec, Inc., where he continues to contribute to innovative research in the pharmaceutical industry. His dedication to developing effective cancer treatments has positioned him as a key figure in his field.

Collaborations

Takeshi has collaborated with notable colleagues, including Akito Tanaka and Tadashi Shimizu, to advance research and development in anticancer therapies.

Conclusion

Takeshi Kanno's contributions to the field of cancer treatment through his innovative patent highlight his importance as an inventor. His work continues to inspire advancements in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…